I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 21 filers reported holding I MAB in Q2 2020. The put-call ratio across all filers is - and the average weighting 4.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,972 | -55.6% | 10,693 | -48.7% | 0.00% | -50.0% |
| Q1 2023 | $72,068 | +39.8% | 20,829 | +68.9% | 0.00% | 0.0% |
| Q4 2022 | $51,535 | -82.0% | 12,329 | -83.3% | 0.00% | -77.8% |
| Q3 2022 | $287,000 | -66.9% | 73,858 | -4.0% | 0.01% | -65.4% |
| Q2 2022 | $867,000 | +86.9% | 76,960 | +169.1% | 0.03% | +116.7% |
| Q1 2022 | $464,000 | -55.5% | 28,602 | +30.0% | 0.01% | -55.6% |
| Q4 2021 | $1,042,000 | -37.7% | 21,994 | -4.6% | 0.03% | -47.1% |
| Q3 2021 | $1,672,000 | -22.1% | 23,066 | -9.7% | 0.05% | -21.5% |
| Q2 2021 | $2,145,000 | -8.5% | 25,554 | -47.1% | 0.06% | -17.7% |
| Q1 2021 | $2,343,000 | -5.4% | 48,347 | -8.0% | 0.08% | -21.8% |
| Q4 2020 | $2,478,000 | +521.1% | 52,550 | +518.9% | 0.10% | +405.0% |
| Q3 2020 | $399,000 | -14.0% | 8,491 | -45.3% | 0.02% | -16.7% |
| Q2 2020 | $464,000 | +79.8% | 15,516 | -21.7% | 0.02% | +41.2% |
| Q1 2020 | $258,000 | – | 19,822 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sage Partners Ltd | 2,054 | $23,000 | 100.00% |
| Cederberg Capital Ltd | 2,215,385 | $25,034,000 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,232 | $553,000,000 | 5.77% |
| IvyRock Asset Management (HK) Ltd | 613,356 | $6,931,000 | 4.38% |
| Zeal Asset Management Ltd | 194,538 | $2,060,000 | 4.25% |
| EDBI Pte Ltd | 222,136 | $2,510,000 | 2.33% |
| HHLR ADVISORS, LTD. | 7,182,850 | $81,166,000 | 1.74% |
| Old Well Partners, LLC | 125,325 | $1,416,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 3,324,000 | $37,561,000 | 0.66% |
| Maso Capital Partners Ltd | 100,000 | $1,130,000 | 0.64% |